(Q45879751)

17 December 2017

title

Same day outpatient transjugular liver biopsies in haemophilia (English)

1 reference

17 December 2017

0 references

0 references

Saab S

1

1 reference

17 December 2017

Cho D

2

1 reference

17 December 2017

Quon DV

3

1 reference

17 December 2017

Ibrahim AB

4

1 reference

17 December 2017

Dong P

5

1 reference

17 December 2017

Marder V

6

1 reference

17 December 2017

Logan L

7

1 reference

17 December 2017

publication date

1 November 2004

1 reference

17 December 2017

published in

Haemophilia

1 reference

17 December 2017

volume

10

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

page(s)

727-731

1 reference

17 December 2017

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01043.X

1 reference

The scientific challenge of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01043.X

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01043.X

The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01043.X

The natural history and antiviral treatment of hepatitis C in haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01043.X

Diagnosis, management, and treatment of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01043.X

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01043.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01043.X

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01043.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01043.X

Classification of chronic hepatitis: diagnosis, grading and staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01043.X

A combined management protocol for patients with coagulation disorders infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01043.X

Liver biopsy in hemophilia A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01043.X

Liver biopsy in Irish hepatitis C-infected patients with inherited bleeding disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01043.X

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01043.X

Hepatitis C in adults and adolescents with hemophilia: a randomized, controlled trial of interferon alfa-2b and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.01043.X

10.1111/J.1365-2516.2004.01043.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017